Trial · NCT02864004
Apomorphine Pump in Early Stage of Parkinson's Disease (EARLY-PUMP)
NCT02864004, Phase 3, Completed, Rennes University Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Apomorphine Pump in Early Stage of Parkinson's Disease (EARLY-PUMP). Trials, record NCT02864004. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02864004
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Apomorphine Pump in Early Stage of Parkinson's Disease (EARLY-PUMP)
- NCT number
- NCT02864004
- Status
- Completed
- Phases
- Phase 3
- Enrollment
- 134 participants, actual
- Lead sponsor
- Rennes University Hospital
- Conditions
- Parkinson's Disease
- Interventions
- Apomorphine, Best Medical Treatment
- First posted
- 2016-08-11
- Last updated
- 2026-06-16
Source ClinicalTrials.gov
Registered outcomes26
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Difference in the Parkinson's Disease Quality of Life Questionnaire (PDQ39) summary index between the baseline assessment and the assessment at 12 months' follow up | 12 months | |
| Secondary | Change in the Patient Global Impression of Change (PGIC) | 12 months | |
| Secondary | Change in the Neurologist Global Impression of change (CGI-I) | 12 months | |
| Secondary | Change in non-motor aspects of experiences of daily living (MDS-UPDRS I) between the baseline assessment and the assessment at 12 months' follow up | 12 months | |
| Secondary | Change in motor aspects of experiences of daily in "on" and "off" medication (MDS-UPDRS II) between the baseline assessment and the assessment at 12 months' follow up | 12 months | |
| Secondary | Change in motor examination during "on" periods (MDS-UPDRS III) between the baseline assessment and the assessment at 12 months' follow up | 12 months | |
| Secondary | Change in motor complications with MDS-UPDRS IV between the baseline assessment and the assessment at 12 months' follow up | 12 months | |
| Secondary | Change in number of hours per day in the "best ON" state between the baseline assessment and the assessment at 12 months' follow up | 12 months | |
| Secondary | Change in number of hours per day in "ON" with dyskinesia between the baseline assessment and the assessment at 12 months' follow up | 12 months | |
| Secondary | Change in number of hours per day in "OFF" state between the baseline assessment and the assessment at 12 months' follow up | 12 months |
1 to 10 of 26Source ClinicalTrials.gov
See all 26 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02864004
GET https://conductscience.org/api/trials/v1/NCT02864004/registered?page=2